Form 13D/A TruBridge For: 10 July
- Investing.com
Soaring Performance | TruBridge's remarkable 196% return over the past year and strong Q4 2024 results showcase its resilience and growth in the healthcare technology secto |
Financial Health | Explore TruBridge's improved balance sheet, with leverage reduced from 4x to 3x, positioning the company for future growth and potential investments |
Strategic Initiatives | Delve into TruBridge's offshoring plans and expansion into new market segments, aiming to support 60% of clients by 2025 and drive operational efficiency |
Market Outlook | Analysts project continued growth with price targets ranging from $10 to $29, as TruBridge navigates competitive pressures and regulatory uncertainties |
Metrics to compare | TBRG | Peers Peers - average of corresponding metrics from companies closely matching TBRG: | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipTBRGPeersSector |
|---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | −0.2x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 2.6x | |
Price / LTM Sales | 0.0x | 0.0x | 2.8x | |
Upside (Analyst Target) | - | 0.0% | 65.5% | |
Fair Value Upside | Unlock | 0.0% | 8.9% | Unlock |